COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Could A Fear Of QbD Slow Your Breakthrough Therapy Drug 8.16.17

30 Jan 2018

The pharmaceutical industry’s evolution from one that relies on the high revenue of blockbuster drug...

What Value Can An Integrated Solution Bring To Your Outsourcing Strategy FINAL

24 Jan 2018

Growing competition across the globe, clinical attrition, the complexity and costs of drug developme...

Quality by design (QbD) in pharmaceutical development

24 Jan 2018

Quality by design (QbD) is a systematic approach to product development that begins with predefined...

Liposome Drug Delivery

24 Jan 2018

The global market for NDDS in cancer therapy was valued at USD 3,655.3 million in 2013 and is expect...

Integrated Solutions for Extractables and Leachables

24 Jan 2018

Studies of extractable and leachable components (E&L) within packaging systems and pharmaceutical co...

Impurity profiling

24 Jan 2018

The stringent regulatory norms and the efforts for the control of impurities in pharmaceutical produ...